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gency department evaluation of patients with acute 
myocardial infarction. The addition of a lipid collec- 
tion tube to an existing clinical/laboratory pathway 
for acquisition of baseline cardiac enzymes is an 
ideal collection method. Even though the presence 
of nonfasting triglyceride levels produced a 5% 
lower Friedewald LDL estimate, the calculation did 
correlate well with the gold standard of ultracentri- 
fugation, as does measurement by the immunosep- 
aration method. In other words, the Friedewald mea- 
surement provides the same specificity with slightly 
less sensitivity than the other methods: All patients 
who were eligible for treatment or who had an LDL 
level >lOO were correctly classified, but 1 patient 
(2%) with LDL <lOO was misclassified as not eli- 
gible for antilipemic intervention, based on the Na- 
tional Cholesterol Education Program guidelines.6 
The definition of the LDL cholesterol level at the 
time of an acute myocai-dial infarction provides phy- 
sicians with an opportunity to address risk factor re- 
duction during hospitalization rather than waiting 3 
months after the event. This period of time may rep- 
resent a window of opportunity for patient education 
about the role of elevated cholesterol and the pro- 
vision of antilipemic therapy for secondary preven- 
tion of coronary artery disease. The initiation of an- 
tilipemic therapy for patients experiencing an acute 
myocardial infarction and who have an elevated 
LDL cholesterol has not yet been clearly defined, but 
a recent consensus committee suggested 4 to 6 weeks 
after the event.6 
The measurement of LDL cholesterol by any of 
the 3 methods described above identifies patients el- 
igible for treatment with antilipemic interventions. 
Accumulating evidence suggests that aggressive 
lipid-lowering therapy reduces the number of recur- 
rent events, improves cardiac and overall mortality 
and improves the regulation of coronary arterial tone 
in patients with atherosclerosis.7’8 It has also been 
demonstrated that beneficial effects can be seen as 
early as 3 months after the start of lipid-lowering 
therapy.g Aggressive lipid lowering may prove to be 
a key part of therapy immediately after acute myo- 
cat-dial infarction. 
In summary, we conclude that lipid screening 
can be introduced into the emergency department 
clinical pathway for evaluation and treatment of 
patients admitted for acute chest pain or myocar- 
dial infarction despite the nonfasting state of most 
such patients by use of any of 3 methods of LDL 
determination. 
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D etection of myocardial ischemia is the hallmark ited accuracy in this clinical setting.3 Recent studies of noninvasive evaluation of graft function I-5 have demonstrated ahigh accuracy of exercise echo- 
after coronary artery bypass grafting (CABG) . Ex- cardiography for the detection of significant graft or 
ercise electrocardiography was shown to have a lim- progressive native coronary artery stenosis.3-5 How- 
ever, an alternative stress modality is required for 
From the Thoraxcenter, University Hospital Rotterdam-Dijkzigt and patients with limited exercise capacity. 
Erasmus University, Rotterdam, The Netherlands. This study was sup . . . 
ported in part by Grant NHS 94-l 3.5 from the Department of Car- 
diolo y Cairo University Hospital, Cairo, Egypt, and the Dutch Heart 
The value of dobutamine stress echocardiography 
Foun 3 ‘. atron, Den Haag, The Netherlands. Dr. Fioretti’s address is: 
in the diagnosis and functional assessment of coro- 
Thoraxcenter, Ba 302, Dr Molewaterplein 40, 30 15 GD Rotterdam, 
nary artery disease has been established in various 
The Netherlands. Manuscript received November 14, 1995; revised clinical indications. G” However, its role in the as- 
manuscript received and accepted January 9, 1996. sessment of patients after CABG has not been stud- 
1234 01996 by Excerpta Medica, Inc. 0002.9149/96/$15.00 
All rights reserved. PII SOOO2-9149(96)00171-3 
ied. Therefore, the aim of this study 
was to assess the value of dobut- 
amine stress echocardiography in 
the diagnosis of vascular compro- 
mise in CABG patients who were 
unable to perform adequate xercise 
stress testing. 
The study population comprised 
50 patients (mean age 58 * 9 years; 
41 men and 9 women) unable to 
perform exercise stress testing who 
were studied by dobutamine stress 
echocardiography 3 months to 19 
years after CABG (mean 5.1 t 5.4 
TABLE I Sensitivity, Specificity, and Accuracy of Dobutamine Stress 
Echocardiography for Diagnosis of Significant Stenosis in individual Vascular 
Regions in Patients With Previous Coronary Artery Bypass Grafting 
Sensitivity Specificity Accuracv 
Left anterior descending artery (14/22) 64% (24/28) 86% (38/50) 76% 
95% Cl 50-77 76-95 64-88 
Left circumflex artery (1 O/20) 50% (24/30) 80% (34/50) 68% 
95% Cl 36-64 69-9 1 55-8 1 
Right coronary artery (9/20) 45% (23/30) 77% (32/50) 64% 
95% Cl 31-59 64-88 50-77 
left circumflex and/or right coronary artery (16/25) 64% (2 l/25) 84% (37/50) 74% 
95% Cl 51-77 74-94 62-86 
Cl = confidence interal. 
years, range 3 months to 19 years). Thirty-nine pa- 
tients (78%) had had a previous myocardial infarc- 
tion, and 15 (30%) were receiving p blockers. Rea- 
sons for stress tests were chest pain in 36 patients 
and exertional dyspnea in 2; in 12 patients the test 
was performed for routine functional assessment. 
Dobutamine-au-opine (dobutamine 540 pglkgl 
min, atropine 51 mg) stress echocardiography was 
performed according to the previously described pro- 
tocol.‘* Ischemia was defined as new or worsening wall 
motion abnormalities. Ischemia on the electrocardio- 
gram was defined as 20.1 mV horizontal or down- 
sloping ST-segment depression 80 ms from the J point 
or 20.1 mV ST-segment elevation corresponding to 
noninfarcted regions.‘* Coronary angiography was per- 
formed within 3 months. Significant coronary artery 
disease was defined quantitatively I3 as a stenosis di- 
ameter 250% in a graft or native artery if the stenosis 
was distal to the graft or involved nongrafted artery. 
There was no significant vascular compromise in 18 
patients, whereas 32 patients had graft or nongrafted 
coronary artery stenosis. 
Heart rate increased from 70 + 12 to 135 + 18 
beats/mm at peak stress (p <O.OOl ), whereas systolic 
blood pressure did not change significantly ( 128 ? 20 
vs 127 2 26 mm Hg ) . Angina occurred in 15 patients 
(30%)) ST-segment depression in 13 (26%)) and ST- 
segment elevation in 10 (20%) ; in these patients, the 
condition was confined to infarction leads. The test was 
interrupted before the maximal dose or target heart rate 
was reached because of angina (n = 5 ) , ST-segment 
depression (n = l), hypotension (n = 2), and tachy- 
arrhythmias (n = 1) . ST-segment depression occurred 
in 10 patients with vascular compromise (3 had single 
region and 7 multiregion compromise) and in 3 pa- 
tients without vascular compromise (sensitivity 3 1%; 
95% confidence interval [ CI] 18 to 44, specificity 
83%; CI 73 to 94, positive predictive value 77%; CI 
65 to 89, negative predictive value 41%; CI 27 to 54; 
accuracy 50%; CI 36 to 64). 
Ischemia was detected during echocardiography 
in 25 of 32 patients with vascular compromise and 
in 2 of the 18 patients without it (sensitivity 78%; 
CI 67 to 90, specificity 89%; CI 80 to 98, positive 
predictive value 93%; CI 85 to 100, negative predic- 
tive value 70%; CI 57 to 82; accuracy 82%; CI 71 
to 93). Sensitivity and accuracy were higher than 
electrocardiography (p <O.OOOl and <O.OOl, re- 
spectively). Sensitivity was 64% (7 of 11) in pa- 
tients with vascular compromise in 1 region, 83% 
(10 of 12) in 2 regions, and 89% (8 of 9) in 3 
regions. There was a trend to higher sensitivity in 
patients with multivessel compromise compared 
with those with l-vessel compromise (86% [ 18 of 
211 vs 64% [7 of 111, p <O.l). In patients with 
vascular compromise, peak heart rate was higher in 
patients with ischemia than without it at echocardi- 
ography ( 135 + 22 vs 120 t 18 beats/min, p 
<0.05). Sensitivity was relatively higher with than 
without achievement of 85% of the target heart rate 
(86% [19 of 221 vs 60% [6 of lo]), respectively. 
An ischemic pattern in 2 different vascular territo- 
ries, suggestive of multivessel compromise, occurred 
in 12 of 21 patients (57%) with multivessel and in 
2 of 11 ( 18%) patients with l-vessel compromise 
(sensitivity 57%; CI 40 to 74, specificity 82%; CI 68 
to 95, positive predictive value 86%; CI 74 to 98, 
negative predictive value 50%; CI 33 to 67; accuracy 
66%; CI 49 to 82). The sensitivity, specificity, and 
accuracy of dobutamine stress echocardiography for 
detection of regional vascular compromise are listed 
in Table I. With the use of 2 myocardial regions (left 
anterior descending [LAD] and combined left cir- 
cumflex [ LCX] and right coronary artery), ischemia 
was detected in 30 of 47 regions with vascular com- 
promise (7 of 12 native arteries and 23 of 35 grafts) 
and in 8 of 53 regions without vascular compromise 
(2 of 13 native arteries and 6 of 40 grafts) (sensitiv- 
ity 64%, specificity 85%). Sensitivity and specificity 
were not different in graft versus native arteries 
(66% [23 of 351 vs 58% [7 of 121 and 85% [34 of 
401 vs 85% [ll of 131, respectively). Sensitivity in 
each vascular region was not different in the pres- 
ence or absence of myocardial infarction in the same 
region (60% vs 65% in LAD and 69% vs 58% in 
the right coronary artery/LCX region, respectively, 
p = NS ) . Of the 8 false-positive regional diagnoses, 
3 occurred in relation to lesions between 40% and 
50%, and 4 occurred in regions with normal wall 
motion at rest. A false-positive diagnosis of ischemia 
in the septum occurred in 2 patients. Septal motion 
at rest was abnormal in 1. 
. . . 
Coronary artery bypass grafting is an effective 
intervention for symptomatic relief, prolonged sur- 
vival, and improvement of left ventricular function 
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in a particular subset of patients with coronary artery 
disease. l4 However, myocardial perfusion after sur- 
gery may be compromised by late graft occlusion 
and progression of coronary artery disease in non- 
grafted or grafted coronary arteries distal to the by- 
pass.15 Our study shows that dobutamine stress echo- 
cardiography is a moderately sensitive and highly 
specific technique for detection of vascular compro- 
mise in these patients. Sensitivity was relatively high 
in the presence of vascular compromise in > 1 re- 
gion. In individual vascular territories, sensitivity 
was not different in the presence or absence of myo- 
cardial infarction in the corresponding region. De- 
spite the known effect of CABG on septal motion, l6 
only 1 of the 8 false-positive results involved the 
septum with abnormal wall motion at rest. 
The sensitivity (78%) and specificity (89%) of 
dobutamine echocardiography are aligned with those 
of the largest exercise echocardiographic study (79% 
and 82%, respectively) in patients after CABG.3 
Sensitivity and specificity of dobutamine echocar- 
diography in our study are comparable to those re- 
ported in patients without CABG,6-10 denoting the 
absence of particular limitations in this population. 
Localization of inducible wall motion abnormal- 
ities identified the area of vascular compromise in a 
high proportion of segments. Improvement of re- 
gional sensitivity and specificity by combining the 
right coronary artery and LCX territories can be ex- 
plained by the vascular overlap previously described 
in these regions.4 Using the 2-segment model, an 
equal sensitivity was found in anterior (LAD) and 
posterior (right coronary artery and LCX) regions. 
There was a relatively low sensitivity for identifying 
multivessel disease on the basis of inducible abnor- 
malities in > 1 region (57%)) which is slightly lower 
than that of exercise echocardiography (69%) re- 
ported by Kafka et a1.3 This can be explained by 
vascular overlap and different threshold for ischemia 
in different vascular territories with the potential to 
reach an end point of the test (angina, electrocardio- 
graphic, or hemodynamic changes and maximal do- 
butamine dose) before the occurrence of ischemia in 
other territories. In patients with vascular compro- 
mise, peak heart rate was higher in patients with isch- 
emia than without at echocardiography consistent 
with the previous findings on dobutamine17 and ex- 
ercise echocardiography. l* 
The limitations of this study are the relatively 
small number of patients and the inclusion of pa- 
tients with previous myocardial infarction. Some pa- 
tients were receiving medication, including 30% 
who were receiving p blockers, which may decrease 
the sensitivity of dobutamine stress echocardiogra- 
phy. Nevertheless, we have previously shown that 
administration of atropine enhances the sensitivity of 
dobutamine stress echocardiography, especially in 
patients receiving /3 blockers.” It is not known if the 
50% diameter stenosis used to define a significant 
native artery stenosis would apply to bypass grafts 
to predict functional abnormalities as defined previ- 
0us1y~-~ and in this study. However, we could not 
find a difference in sensitivity and specificity in myo- 
cardial regions with native or grafted arteries. A par- 
ticular difficulty would arise in regions of vascular 
overlap between native and grafted arteries if a dif- 
ferent cutoff point were used to define coronary ste- 
nosis in each artery. 
In .conclusion, dobutamine stress echocardiog- 
raphy is an accurate method for diagnosis of vas- 
cular compromise in patients after CABG and pro- 
vides useful data for selection of patients for whom 
coronary angiography may be indicated. 
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